Redmond Asset Management’s IDEAYA Biosciences IDYA Stock Holding History

Redmond Asset Management’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-12,754	Closed	-$560K	–	160
2024 Q1	$560K	Sell	12,754 -40	-0.3%	-$1.72K	0.18%	117
2023 Q4	$455K	Sell	12,794 -243	-2%	-$7.25K	0.15%	129
2023 Q3	$352K	Hold	13,037	–	–	0.13%	134
2023 Q2	$306K	Hold	13,037	–	–	0.1%	140
2023 Q1	$179K	Hold	13,037	–	–	0.06%	158
2022 Q4	$237K	Buy	13,037 +337	+3%	+$5.67K	0.09%	156
2022 Q3	$189K	Sell	12,700 -20	-0.2%	-$260	0.07%	162
2022 Q2	$176K	Hold	12,720	–	–	0.06%	176
2022 Q1	$142K	Buy	12,720 +65	+0.5%	+$958	0.04%	184
2021 Q4	$299K	Buy	12,655 +689	+6%	+$16K	0.08%	176
2021 Q3	$305K	Buy	11,966 +1,112	+10%	+$26K	0.1%	169
2021 Q2	$228K	Hold	10,854	–	–	0.07%	181
2021 Q1	$255K	Buy	+10,854	New	+$210K	0.08%	180

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Redmond Asset Management's IDYA Position: Q2 2024 in Review

Redmond Asset Management sold out of IDEAYA Biosciences (IDYA) in Q2 2024, closing a stake of 12,754 shares — an estimated $560K sold.

Redmond Asset Management first reported a position in IDYA in Q1 2021 and held it in 13 quarters. The position peaked at $560K in Q1 2024. 199 funds tracked by Wall St. Rank hold IDYA as of Q2 2024.

Redmond Asset Management reported no remaining IDEAYA Biosciences position as of Q2 2024 after selling out during the quarter.
Redmond Asset Management sold 12,754 IDEAYA Biosciences shares in Q2 2024, an estimated $560K.
Redmond Asset Management first reported a position in IDEAYA Biosciences in Q1 2021 and held it in 13 quarters.
Redmond Asset Management's IDEAYA Biosciences position peaked at $560K in Q1 2024.
199 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2024.

Based on Redmond Asset Management's 13F filing for Q2 2024, filed 9 Aug 2024.